GFPC
ARKG icon

Global Financial Private Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Global Financial Private Capital’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-325
Closed -$11K – 389
2019
Q2 		$11K Buy
+325
New +$10.4K ﹤0.01% 364

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return

Global Financial Private Capital's ARKG Position: Q3 2019 in Review

Global Financial Private Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2019, closing a stake of 325 shares — an estimated $11K sold.

Global Financial Private Capital first reported a position in ARKG in Q2 2019 and held it in 1 quarter. The position peaked at $11K in Q2 2019. 80 funds tracked by Wall St. Rank hold ARKG as of Q3 2019.

  • Global Financial Private Capital reported no remaining ARK Genomic Revolution ETF position as of Q3 2019 after selling out during the quarter.
  • Global Financial Private Capital sold 325 ARK Genomic Revolution ETF shares in Q3 2019, an estimated $11K.
  • Global Financial Private Capital first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 1 quarter.
  • Global Financial Private Capital's ARK Genomic Revolution ETF position peaked at $11K in Q2 2019.
  • 80 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2019.

Based on Global Financial Private Capital's 13F filing for Q3 2019, filed 13 Nov 2019.